Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Results 1 - 20 of 71 : 1 2 3 4 Next »

Recs

0
Member Avatar keelfoot (< 20) Submitted: 6/26/2014 11:20:30 AM : Outperform Start Price: $15.55 KERX Score: -10.91

Getting close to success with key much needed diabetes drugs.

Recs

0
Member Avatar 78taxs (< 20) Submitted: 6/24/2014 12:08:55 PM : Outperform Start Price: $15.49 KERX Score: -9.71

treatment for diabetes

Recs

0
Member Avatar SkepBioInvestor (97.15) Submitted: 5/15/2014 6:29:19 PM : Underperform Start Price: $12.89 KERX Score: -4.60

Zere-crap will get a CRL by June 7

Recs

0
Member Avatar chitownatiiive (< 20) Submitted: 1/30/2014 8:08:49 PM : Outperform Start Price: $15.51 KERX Score: -21.31

i feel it. im brand at trying ive attempted to study the market but have been lazy this is a lucky guess based on how its already moving upward and is rated 80% bullish

Recs

0
Member Avatar Litigation (< 20) Submitted: 3/16/2013 7:15:33 PM : Outperform Start Price: $7.25 KERX Score: +70.19

Price Target: $13

Recs

0
Member Avatar scrubs62074 (71.60) Submitted: 1/23/2013 2:03:57 PM : Outperform Start Price: $3.81 KERX Score: +249.85

High volume breakout 1/23/13

Recs

0
Member Avatar NHWeston102 (63.61) Submitted: 7/6/2012 10:13:26 PM : Outperform Start Price: $1.93 KERX Score: +613.77

Outclassed in all its categories but a fair buy-out candidates.

Recs

0
Member Avatar Robase06 (< 20) Submitted: 5/23/2012 10:12:36 PM : Outperform Start Price: $1.78 KERX Score: +675.19

Zerenex

Recs

0
Member Avatar TXKL (< 20) Submitted: 5/16/2012 4:05:00 PM : Outperform Start Price: $1.85 KERX Score: +644.02

Big buyout rumors.

Recs

0
Member Avatar someboy0808 (< 20) Submitted: 5/11/2012 6:47:34 PM : Outperform Start Price: $1.98 KERX Score: +593.21

Top line Positive phase 3 drug report from Japan, and 100million license fee, you know this company is not going down any time soon!

Recs

0
Member Avatar wcaddict (< 20) Submitted: 4/23/2012 12:10:52 PM : Outperform Start Price: $1.71 KERX Score: +713.99

news

Recs

0
Member Avatar Stef100000 (< 20) Submitted: 4/10/2012 1:22:13 PM : Underperform Start Price: $1.42 KERX Score: -889.90

No future

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 4/2/2012 5:36:17 PM : Outperform Start Price: $1.69 KERX Score: +729.34

bravo

Recs

0
Member Avatar WRXkid (84.37) Submitted: 3/29/2012 2:01:49 PM : Outperform Start Price: $4.83 KERX Score: +158.14

Possible positive outcome of clinical trials for perifosine.

Recs

0
Member Avatar saulucy20 (< 20) Submitted: 3/16/2012 6:02:54 AM : Outperform Start Price: $4.18 KERX Score: +206.69

Phase 3 on Perifosine

Recs

0
Member Avatar RBuskey106 (50.71) Submitted: 3/14/2012 10:42:20 PM : Outperform Start Price: $4.10 KERX Score: +213.34

Betting on perifosine for the short term bump

Recs

0
Member Avatar KimLanners (< 20) Submitted: 10/14/2011 1:51:20 PM : Outperform Start Price: $2.79 KERX Score: +360.70

biotech

Recs

0
Member Avatar vaderblue (< 20) Submitted: 8/31/2011 5:00:26 PM : Outperform Start Price: $4.11 KERX Score: +190.98

I am an investor of Kerx for along time. I am hinting this is a must deal for them. Good news today but like
having babies, we must wait it out.

Recs

0
Member Avatar bikesncats (28.97) Submitted: 7/15/2011 4:25:23 AM : Outperform Start Price: $4.92 KERX Score: +143.75

Phase 3 trials will show if this "lottery ticket" has what is takes to become a 10 bagger, I believe so.

Recs

0
Member Avatar almostgem (< 20) Submitted: 6/9/2011 2:51:10 PM : Outperform Start Price: $4.83 KERX Score: +147.20

See Aezs - This company has exclusive rights to market a cancer drug that is now in stage III trials. If successful, both companies should soar !

Results 1 - 20 of 71 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement